Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNAs mediated Hsa21 gene suppression as potential therapeutic agent for Down syndrome: molecular dynamics and MM/PBSA-based study. | J Mol Model | 2026 | 41603953 | PubTator, text mining | PubMed |
| The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome. | Alzheimers Dement (Amst) | 2026 | 41561734 | PubTator, text mining | PubMed |
| Evaluation of [18F]MK-6240 binding to tau protein in postmortem human brains of Down syndrome and Alzheimer's disease and assessment of off-target (non-tau) binding. | Res Sq | 2026 | 41542065 | PubTator, text mining | PubMed |
| Dual FLT3/PIM inhibitor dapolsertib in acute myeloid leukemia: results from the phase 1/2 DIAMOND-01 trial. | Blood Neoplasia | 2026 | 41536779 | PubTator, text mining | PubMed |
| FAM117B Promotes Colorectal Cancer Progression by Enhancing DYRK1A-mediated Phosphorylation of PLK2. | Cell Biol Int | 2026 | 41504297 | PubTator, text mining | PubMed |
| Chemical Constituents and Biological Activities of Oxandra (Annonaceae): A Review. | Chem Biodivers | 2026 | 41494962 | PubTator, text mining | PubMed |
| Correlation between tight binding of inhibitors and their target selectivity toward the non-native state in the DYRK family of kinases. | Bioorg Med Chem Lett | 2026 | 41461351 | PubTator, text mining | PubMed |
| SF3B1K700E rewires splicing of cell cycle regulators. | RNA | 2026 | 41443830 | PubTator, text mining | PubMed |
| Multifaceted role of primary cilia and ciliary proteins: A potential nexus for hedgehog signaling and prostate cancer. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41242563 | PubTator, text mining | PubMed |
| Exploring the Functional and Prognostic Significance of miR-217 in Uterine Corpus Endometrial Carcinoma. | Curr Med Chem | 2026 | 40304329 | PubTator, text mining | PubMed |
| Monogenic Findings in Early Pregnancy Loss: Whole-Exome Sequencing Study of Euploid Products of Conception. | Balkan J Med Genet | 2025 | 42147992 | PubTator, text mining | PubMed |
| Harmine Selectively Drives Human Beta Cell Differentiation and Function Via Protein Kinase A Pathways. | bioRxiv | 2025 | 41573826 | PubTator, text mining | PubMed |
| Carboline Hybrids as Potential Multitarget-Directed Anti-Alzheimer's Disease Agents: A Comprehensive Analysis of Design Strategies and Structure-Activity Relationships. | Arch Pharm (Weinheim) | 2025 | 41457307 | PubTator, text mining | PubMed |
| Geometry-based BERT: An experimentally validated deep learning model for molecular property prediction in drug discovery. | J Pharm Anal | 2025 | 41446890 | PubTator, text mining | PubMed |
| Critical role of the CMGC insert sequence for tyrosine autophosphorylation in the protein kinase DYRK1B. | Sci Rep | 2025 | 41444824 | PubTator, text mining | PubMed |
| Correction to "AI-Driven De Novo Design and Development of Nontoxic DYRK1A Inhibitors". | J Med Chem | 2025 | 41358654 | PubTator, text mining | PubMed |
| FeaSion decodes the regulatory landscape and functional diversity of RNA polymerase II CTD phosphorylation. | Sci Adv | 2025 | 41313762 | PubTator, text mining | PubMed |
| Identification and Validation of an inhibitor of the protein kinases PIM and DYRK. | bioRxiv | 2025 | 41279372 | PubTator, text mining | PubMed |
| Novel small-molecule inhibitors of the protein kinase DYRK: Potential therapeutic candidates in cancer. | bioRxiv | 2025 | 41278673 | PubTator, text mining | PubMed |
| DYRK1A in the physiology and pathology of the neuron-astrocyte axis. | Front Neurosci | 2025 | 41189746 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers?page=5